← Back to Search

Behavioural Intervention

W-SUDs for Substance Use Disorder

Phase 2
Waitlist Available
Led By Judith Prochaska, PhD
Research Sponsored by Woebot Labs, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to mid-treatment at 4 weeks; change from baseline to post-treatment at 8 weeks; change from baseline to follow-up at 12 weeks
Awards & highlights

Study Summary

This trialtests a mobile-app program (W-SUDs) to reduce substance use vs. a control condition to see if it works.

Eligible Conditions
  • Substance Use Disorder
  • Alcoholism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to mid-treatment at 4 weeks; change from baseline to post-treatment at 8 weeks; change from baseline to follow-up at 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to mid-treatment at 4 weeks; change from baseline to post-treatment at 8 weeks; change from baseline to follow-up at 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Alcohol or Other Drugs use
Secondary outcome measures
Brief Situational Confidence Questionnaire (BSCQ)
Client Satisfaction Questionnaire (CSQ)
Craving Ratings
+10 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: W-SUDsExperimental Treatment1 Intervention
Woebot (W-SUDs), a Conversational Agent (CA) instantaneously available 24 hours per day, 7 days per week, 'checks in' with users. Using conversational tones, it encourages mood tracking and delivers general psychoeducation as well as tailored empathy, cognitive behavior therapy (CBT)-based behavior change tools, and behavioral pattern insight. Woebot's app-based platform and user-centered design philosophy makes it an optimal modality for Substance Use Disorders (SUD) treatment delivery. It offers immediate, evidence-based tailored support in the patient's peak moment of craving.
Group II: Digitally-delivered PsychoeducationExperimental Treatment1 Intervention
Psychoeducation delivers weekly fact sheets that include information on: Alcohol-specific topics; Drug-specific topics; General addiction topics; Statistics relating to alcohol and substance use.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
W-SUDs
2022
Completed Phase 2
~280

Find a Location

Who is running the clinical trial?

Woebot Labs, Inc.Lead Sponsor
6 Previous Clinical Trials
521 Total Patients Enrolled
Stanford UniversityOTHER
2,406 Previous Clinical Trials
17,342,887 Total Patients Enrolled
Woebot HealthLead Sponsor
13 Previous Clinical Trials
1,686 Total Patients Enrolled
~103 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top